http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014516952-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 |
| filingDate | 2012-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014516952-A |
| titleOfInvention | Combination of solifenacin and salivary stimulant for the treatment of overactive bladder |
| abstract | Disclosed herein are pharmaceutical compositions comprising a therapeutically effective amount of sustained release solifenacin or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of pilocarpine or a pharmaceutically acceptable salt thereof. A method of treating a patient suffering from overactive bladder, the identification of the patient in need thereof and a therapeutically effective amount of sustained-release solifenacin or a pharmaceutically acceptable product thereof Also disclosed herein is a method comprising administering a salt and a therapeutically effective amount of pilocarpine or a pharmaceutically acceptable salt thereof. There is also a method for reducing side effects in patients with side effects of overactive bladder treatment, identifying a patient in need thereof, and treating the patient with a therapeutically effective amount of sustained-release solifenacin or pharmaceutically Also disclosed herein are methods comprising administering an acceptable salt and a therapeutically effective amount of pilocarpine or a pharmaceutically acceptable salt thereof. [Selection figure] None |
| priorityDate | 2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.